| Foreword | 67.4 KB |
| Research Programmes | 33 KB |
| Molecular Oncology | 3.5 MB |
| Telomeres and Telomerase Group | 1014.9 KB |
| Experimental Oncology Group | 278.1 KB |
| Cell Division and Cancer Group | 341.5 KB |
| Signalling and Cell Cycle Group | 58.1 KB |
| Tumour Suppression Group | 372.1 KB |
| Genomic Instability Group | 466.2 KB |
| Chromosome Dynamics Junior Group | 209.6 KB |
| DNA Replication Junior Group | 187.4 KB |
| Cell Competition Junior Group | 172.7 KB |
| DNA Hypermutation and Cancer Junior Group | 253.7 KB |
| Structural Biology and Biocomputing | 3.1 MB |
| Structural Computational Biology Group | 717.4 KB |
| Macromolecular Crystallography Group | 411.4 KB |
| Computational Biophysics Junior Group | 172.3 KB |
| Cell Signalling and Adhesion Junior Group | 174.9 KB |
| Structural Bases of Genome Integrity Junior Group | 155.1 KB |
| Spectroscopy and Nuclear Magnetic Resonance Core Unit | 289.7 KB |
| Bioinformatics Core Unit | 137.3 KB |
| National Bioinformatics Institute Core Unit | 147.5 KB |
| BBVA Foundation - CNIO Cancer Cell Biology | 2.5 MB |
| Genes, Development and Disease Group | 517.1 KB |
| Epithelial Cell Biology Junior Group | 217.3 KB |
| Growth Factors, Nutrients and Cancer Junior Group | 167.9 KB |
| Molecular Pathology | 2.6 MB |
| Lymphoma Group | 329.8 KB |
| Epithelial Carcinogenesis Group | 344.8 KB |
| Melanoma Group | 517 KB |
| Tumour Markers Junior Group | 192.3 KB |
| Tumour Bank Core Unit | 265.6 KB |
| Human Cancer Genetics | 2.2 MB |
| Human Genetics Group | 364.9 KB |
| Molecular Cytogenetics Group | 325.3 KB |
| Genetic and Molecular Epidemiology Group | 300.5 KB |
| Hereditary Endocrine Cancer Group | 458.3 KB |
| Human Genotyping-CEGEN Core Unit | 177.8 KB |
| Experimental Therapeutics | 2.5 MB |
| Screening Section | 209 KB |
| Molecular Pharmacology Section | 177.4 KB |
| Biochemistry Section | 187.5 KB |
| Animal Pharmacology Section | 177.2 KB |
| Cell Signalling Therapies Section | 202.8 KB |
| In Vivo Target Validation Section | 191.6 KB |
| Medicinal Chemistry Department | 396.6 KB |
| Medicinal Chemistry I and Analytical Chemistry Section | 221.4 KB |
| Medicinal Chemistry II Section | 170.3 KB |
| Computational Chemistry and Chemoinformatics Section | 138.6 KB |
| Biotechnology | 2.6 MB |
| Proteomics Core Unit | 195.6 KB |
| Comparative Pathology Core Unit | 231.8 KB |
| Genomics Core Unit | 237.2 KB |
| Confocal Microscopy Core Unit | 180.2 KB |
| Molecular Imaging Core Unit | 137.3 KB |
| Transgenic Mice Core Unit | 127.5 KB |
| Monoclonal Antibodies Core Unit | 216 KB |
| Histology and Immunohistochemistry Core Unit | 149.4 KB |
| Flow Cytometry Core Unit | 318 KB |
| Clinical Research | 3 MB |
| Gastrointestinal Cancer Clinical Research Unit | 324.3 KB |
| Stem Cells and Cancer Group | 478.3 KB |
| Breast Cancer Junior Clinical Research Unit | 187.7 KB |
| Molecular Diagnostics Core Unit | 222.4 KB |
| Animal Facility | 1.1 MB |
| Genetically Modified Mouse Strains | 77 KB |
| Facts and Figures | 2.7 MB |
| Scientific Productivity | 131 KB |
| Awards and Recognition | 33.1 KB |
| Training Programmes and Courses | 234.4 KB |
| Conferences, Workshops and Seminars | 1009.5 KB |
| Collaborating Institutions | 50 KB |
| Competitive Funding | 70.9 KB |
| Philanthropy | 196.9 KB |
| Private Sponsors | 173.4 KB |
| Administration | 256.5 KB |